Key result
Long COVID links to lower quality of life past two years despite normal pathophysiological mechanisms.
Why the study?
Following acute SARS-CoV-2 infection, some patients experience persistent debilitating symptoms, prompting investigation into potential pathophysiological mechanisms responsible for long COVID fatigue and exercise intolerance more than 2 years later.
Are there identifiable pathophysiological mechanisms explaining persistent fatigue and exercise intolerance in patients more than 2 years after SARS-CoV-2 infection?
Case-Control (n=26)
Are there identifiable pathophysiological mechanisms explaining persistent fatigue and exercise intolerance in patients more than 2 years after SARS-CoV-2 infection?
Despite persistent debilitating fatigue and lower quality of life >2 years post-COVID, standard physiological and cardiopulmonary evaluations show no significant deficits compared to recovered controls.
Persistent symptoms lack identifiable mechanisms on standard testing; leaves open alternative pathways for mechanistic research.
Following an acute infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a substantial percentage of patients report the persistence of debilitating symptoms, often grouped in a syndrome termed ‘long COVID’. We sought to identify potential pathophysiological mechanisms responsible for the persistence, in some long COVID patients, of symptoms related to fatigue/exercise intolerance (excessive or early fatigue, excessive or early dyspnoea, muscle weakness, and myalgias) more than 2 years after the original infection. Twelve patients who reported persistent symptoms (Long COVID group; 57 ± 6 years, mean ± SD), and 14 patients without the symptoms (Control group; 57 ± 8 years) were evaluated. An extensive series of measurements were performed to identify pathophysiological mechanisms potentially responsible for the symptoms. In long COVID patients, all items evaluating quality of life (SF‐36 questionnaire) had lower scores ( P < 0.01) compared to control. The habitual level of physical activity, muscle size and strength, maximal aerobic power and the ventilatory thresholds, peak cardiac function, the mechanical efficiency of cycling, pulmonary kinetics, microvascular/endothelial function (hyperemic response in the common femoral artery during passive leg movements), skeletal muscle oxidative metabolism (peak fractional O 2 extraction and muscle recovery kinetics by the repeated occlusions test, by near‐infrared spectroscopy) were not different in the two groups. Evidence of ventilatory inefficiency was described in a subgroup of long COVID patients. More than 2 years after the original SARS‐CoV‐2 infection, a discrepancy was observed between the persistence of debilitating symptoms of fatigue/exercise intolerance and the absence of several investigated pathophysiological mechanisms. The discrepancy may be due to factors that remain to be elucidated.
No takes yet. Share an insight, caveat, or question.
Baldassarre et al. (2025) conducted a case-control in Long COVID (n=26). Long COVID (persistent symptoms) vs. Control group (no persistent symptoms) was evaluated on Quality of life (SF-36 questionnaire) and pathophysiological mechanisms of fatigue/exercise intolerance (p=<0.01). More than 2 years post-SARS-CoV-2 infection, long COVID patients had lower quality of life (P<0.01) but no differences in investigated pathophysiological mechanisms compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: